These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20393214)

  • 1. Prevalence of hepatitis C infection in injection drug users in Hong Kong.
    Lee SS
    Hong Kong Med J; 2009 Dec; 15 Suppl 8():45-6. PubMed ID: 20393214
    [No Abstract]   [Full Text] [Related]  

  • 2. A multilevel approach for assessing the variability of hepatitis C prevalence in injection drug users by their gathering places.
    Wong NS; Chan PC; Lee SS; Lee SL; Lee CK
    Int J Infect Dis; 2013 Mar; 17(3):e193-8. PubMed ID: 23165126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the prevalence of hepatitis C virus (HCV) RNA in anti-HCV-positive injection drug users positively correlated with age?
    Matheï C; Buntinx F; Van Damme P
    J Infect Dis; 2001 Sep; 184(5):659-60. PubMed ID: 11494175
    [No Abstract]   [Full Text] [Related]  

  • 4. Indications of immune protection from hepatitis C infection.
    Aitken CK; Bowden S; Hellard M; Crofts N
    J Urban Health; 2004 Mar; 81(1):58-60. PubMed ID: 15047784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of widespread methadone treatment on the molecular epidemiology of hepatitis C virus infection among injection drug users in Hong Kong.
    Chan DP; Lee SS; Lee KC
    J Med Virol; 2011 Jul; 83(7):1187-94. PubMed ID: 21567422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of hepatitis C virus genotypes among intravenous drug users. A ten-year study in Palermo, Sicily.
    Vitale F; Villafrate MR; Viviano E; Perna AM; Bonura F; Di Benedetto MA; Mazzola G; Colletti P; Prestileo T; Romano N
    New Microbiol; 1998 Oct; 21(4):335-42. PubMed ID: 9812314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
    Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands.
    van de Laar TJ; Langendam MW; Bruisten SM; Welp EA; Verhaest I; van Ameijden EJ; Coutinho RA; Prins M
    J Med Virol; 2005 Dec; 77(4):509-18. PubMed ID: 16254983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence study of HCV among hospitalized intravenous drug users in Ahvaz, Iran (2001-2006).
    Alavi SM; Alavi L
    J Infect Public Health; 2009; 2(1):47-51. PubMed ID: 20701860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived barriers to safe-injection practices among drug injectors who remain HCV-negative.
    Stein MD; Dubyak P; Herman D; Anderson BJ
    Am J Drug Alcohol Abuse; 2007; 33(4):517-25. PubMed ID: 17668337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus seroconversion among young injection drug users: relationships and risks.
    Hahn JA; Page-Shafer K; Lum PJ; Bourgois P; Stein E; Evans JL; Busch MP; Tobler LH; Phelps B; Moss AR
    J Infect Dis; 2002 Dec; 186(11):1558-64. PubMed ID: 12447730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C among injecting drug users is two times higher in Stockholm, Sweden than in Rotterdam, the Netherlands.
    Norden L; van Veen M; Lidman C; Todorov I; Guarita B; Kretzschmar M; Wiessing L
    Subst Use Misuse; 2013 Dec; 48(14):1469-74. PubMed ID: 23750711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago.
    Boodram B; Golub ET; Ouellet LJ
    Drug Alcohol Depend; 2010 Sep; 111(1-2):136-45. PubMed ID: 20472373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: "Risk of hepatitis C virus among young adult injection drug users who share injection equipment".
    Koester S; Heimer R; Barón AE; Glanz J; Teng W
    Am J Epidemiol; 2003 Feb; 157(4):376; author reply 376-8. PubMed ID: 12578809
    [No Abstract]   [Full Text] [Related]  

  • 15. High prevalence of HCV in a cohort of injectors on methadone substitution treatment.
    Lee KC; Lim WW; Lee SS
    J Clin Virol; 2008 Apr; 41(4):297-300. PubMed ID: 18191614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of hepatitis C virus testing methods among injecting drug users.
    White B; Day C; Thein HH; Doab A; Bates A; Holden J; van Beek I; Maher L
    Drug Alcohol Rev; 2008 Nov; 27(6):666-70. PubMed ID: 19378449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore.
    Winslow M; Subramaniam M; Ng WL; Lee A; Song G; Chan YH
    Singapore Med J; 2007 Jun; 48(6):504-8. PubMed ID: 17538746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users.
    Burt RD; Thiede H; Hagan H
    Drug Alcohol Depend; 2009 Dec; 105(3):215-20. PubMed ID: 19720473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based molecular epidemiology study of hepatitis C virus infection in injection drug users.
    Chan DP; Lee KC; Lee SS; Tan TY
    Hong Kong Med J; 2017 Aug; 23 Suppl 5(4):27-30. PubMed ID: 28943522
    [No Abstract]   [Full Text] [Related]  

  • 20. Sex differences in injecting practices and hepatitis C: a systematic review of the literature.
    Roman-Crossland R; Forrester L; Zaniewski G
    Can Commun Dis Rep; 2004 Jul; 30(14):125-32. PubMed ID: 15279499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.